What Researchers Did
Researchers prospectively evaluated 25 patients with acute non-cardioembolic stroke treated with HBOT, measuring circulating endothelial progenitor cell counts, oxidative stress markers, and clinical neurological scores before and after treatment, comparing to 25 matched controls.
What They Found
After HBOT, circulating KDR+/CD34+ endothelial progenitor cells increased significantly. High-sensitivity CRP levels decreased significantly. Clinical scores (NIHSS, Barthel Index, modified Rankin Scale) improved, and the increase in endothelial progenitor cells correlated positively with clinical improvement.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a small case-control study of 25 patients; without randomization, selection bias cannot be excluded, and the causality of the endothelial cell changes for clinical improvement remains unproven.